Using virtual reality and relaxing videos to help lung cancer patients
The Effect of Immersive Virtual Reality and Relaxing Videos on Symptom Severity, Distress and Quality of Life in Patients With Lung Cancer Undergoing Chemotherapy
This study tests if using virtual reality and relaxing videos can help lung cancer patients feel less stressed and improve their quality of life during their first chemotherapy treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hacettepe University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Ankara, Altındağ) |
| Trial ID | NCT06863623 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of immersive virtual reality and relaxing video interventions on lung cancer patients undergoing their first chemotherapy treatment. It aims to assess how these non-pharmacological methods can alleviate symptoms such as distress and improve the quality of life for patients experiencing side effects from chemotherapy. Participants will engage with virtual reality applications and relaxing videos to determine their impact on symptom severity and emotional well-being. The study focuses on patients who are receiving at least two cycles of chemotherapy for lung cancer.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have been diagnosed with lung cancer and are about to receive chemotherapy for the first time.
Not a fit: Patients with cognitive or psychiatric disorders, those with specific phobias related to the study interventions, or those who do not agree to participate may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life for lung cancer patients undergoing chemotherapy by reducing distress and improving symptom management.
How similar studies have performed: Previous studies have indicated positive effects of virtual reality and audio-visual therapies on cancer patients, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * are over 18 years old, * diagnosed with lung cancer, * will receive chemotherapy for the first time, * will receive at least 2 cycles of chemotherapy treatment * agree to participate in the study, Exclusion Criteria: * Having a cognitive and psychiatric disorder and diagnosis, * Having brain metastasis or chronic disease related to the head-brain region, * Having vision-hearing problems, * Having epilepsy, vertigo, chronic severe headache, dizziness problems, * Having a history of virtual reality, simulator or motion sickness, * Having/declaring that he/she has open area, underwater, specific animal phobia, * Do not agree to participate in the study
Where this trial is running
Ankara, Altındağ
- Hacettepe University — Ankara, Altındağ, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Kadir BAYSOY, PhD (c)
- Email: kadir.baysoy@gmail.com
- Phone: +905073045536
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.